Genomic informed medical oncology in St. Louis, Missouri

Allen Mo, MD is a renowned doctor specializing in gastrointestinal oncology, with expertise in treating gastric cancer, hepatobiliary cancer, pancreatic cancer, colorectal cancer, and anal cancer. Located at 10 Barnes West Drive in Creve Coeur, Missouri, Dr. Mo's institution offers cutting-edge personalized cancer therapy using genomics and artificial intelligence. His research focuses on utilizing innovative biomedical technology, such as adaptive radiation therapy for gastrointestinal malignancies, with real-time MR and CT guided radiation treatment delivery. Dr. Mo completed his medical training at Montefiore Medical Center - Albert Einstein College of Medicine in Bronx, NY, and UConn School of Medicine/Graduate School of Biomedical Sciences in Farmington, CT. As a member of the Washington University Physicians, Dr. Mo and his team provide top-notch care at Barnes-Jewish Hospital and St. Louis Children's Hospital. For more information, visit the FPP Intranet and connect with Dr. Mo on LinkedIn. Privacy Statement and No Surprises Medical Billing policies are strictly followed at this institution.

Angela C. Hirbe, MD, PhD is a medical institution located at 5225 Midamerica Plaza in St. Louis, Missouri, United States. Specializing in medical oncology, the institution focuses on the treatment of cancer, particularly sarcoma, as well as cancer predisposition syndromes such as NF1, LFS, and SDH. Dr. Hirbe is a practicing medical oncologist with a research interest in utilizing genomic information to better understand the pathogenesis of sarcomas and identify biomarkers and therapeutic targets for these aggressive cancers. The institution is affiliated with Washington University School of Medicine and Washington University Physicians, who are the medical staff of Barnes-Jewish Hospital and St. Louis Children's Hospital. For more information, visit the lab website at hirbelab.wustl.edu.

Dr. Brian Van Tine, MD, PhD is a medical institution specializing in medical oncology, with a focus on cancer, sarcoma, soft tissue sarcoma, bone cancer, leiomyosarcoma, and liposarcoma. Located at 4921 Parkview Place in St. Louis, Missouri, United States, Dr. Van Tine and his team are dedicated to understanding the genomics of osteosarcoma, leiomyosarcoma, and other rare forms of sarcoma. Through the use of mouse genetics, human tumor xenografting, and cancer biology, they aim to identify druggable targets for clinical use. Dr. Van Tine received his training in Hematology and Oncology and Oncology at Washington University School of Medicine in St. Louis, Missouri. The medical staff at Dr. Van Tine's institution are affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital. For more information, visit their FPP Intranet or LinkedIn page. Terms of Use and Privacy Statement are available, and they offer No Surprises Medical Billing.